Ibuprofen + Dexamethasone for Lower Back Pain
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests the effectiveness of combining ibuprofen and dexamethasone (a corticosteroid) for individuals with sudden lower back pain that radiates pain or tingling to their legs. It compares this treatment to a placebo to determine which provides better pain relief. Participants will also receive a brief educational session on managing back pain. This trial suits individuals who have experienced less than two weeks of back pain affecting daily activities and have not had frequent back pain in the past three months. Participants should not have had a recent back injury and must be able to return home after their hospital visit. As a Phase 4 trial, this research aims to understand how this already FDA-approved and effective treatment can benefit more patients.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you use pain medication daily or have chronic steroid use. It's best to discuss your specific medications with the trial team.
What is the safety track record for these treatments?
A previous study showed that common pain relievers like ibuprofen, known as NSAIDs (non-steroidal anti-inflammatory drugs), help reduce pain and disability in people with low back pain. The relief was modest but noticeable. Research also shows that combining ibuprofen with dexamethasone, a type of steroid, can be effective for short-term pain relief. However, some studies suggest that dexamethasone might lead to longer-lasting pain in certain cases.
Ibuprofen is well-known and generally safe when used as directed. Dexamethasone is also widely used but can sometimes cause side effects like increased blood sugar or mood changes. In this trial, both medications are given at standard doses and for a short time, which usually limits the risk of serious side effects.
Overall, these treatments are generally well-tolerated, but like any medication, there can be risks. Participants should ask questions and discuss any concerns with the trial team.12345Why are researchers enthusiastic about this study treatment?
Researchers are excited about combining ibuprofen with dexamethasone for lower back pain because this approach could offer faster and more effective relief than using ibuprofen alone. While ibuprofen is commonly used for its anti-inflammatory properties, adding dexamethasone, a powerful steroid, may enhance pain relief by further reducing inflammation quickly. Additionally, the treatment includes a 15-minute educational intervention, which could improve patient understanding and management of their condition, potentially leading to better outcomes. This combination aims to address pain and inflammation more comprehensively, offering a potentially superior alternative to standard care options like non-steroidal anti-inflammatory drugs (NSAIDs) alone.
What evidence suggests that this trial's treatments could be effective for lower back pain?
In this trial, participants will receive either a combination of ibuprofen and dexamethasone or ibuprofen with a placebo, along with an educational intervention. Research has shown that using ibuprofen with dexamethasone can help manage lower back pain. For example, a study with 160 patients who underwent back surgery found that dexamethasone significantly reduced pain during movement compared to a placebo (a pill with no active medicine). Ibuprofen, a common pain reliever, has also been proven in several studies to reduce pain more effectively than a placebo. This combination targets both inflammation and pain, potentially offering better relief for sudden lower back pain than ibuprofen alone.12367
Who Is on the Research Team?
Eddie Irizarry, MD
Principal Investigator
Montefiore Medical Center
Are You a Good Fit for This Trial?
This trial is for adults aged 18-70 with acute radicular low back pain, which hasn't lasted more than two weeks and radiates from the lower back to the leg. Participants should have a significant level of disability due to their pain but can't have had frequent back pain in the past three months or direct trauma recently. They must not be pregnant, suffer from chronic pain syndromes, or have conditions that make ibuprofen or dexamethasone risky.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive an oral dose of dexamethasone or placebo for 2 consecutive days and a 7-day supply of ibuprofen, along with a low back pain education session
Follow-up
Participants are monitored for safety and effectiveness after treatment via telephone follow-ups
What Are the Treatments Tested in This Trial?
Interventions
- Dexamethasone Oral
- Educational Intervention
- Ibuprofen 400 mg
Ibuprofen 400 mg is already approved in United States, European Union, Canada, Japan, China, Switzerland for the following indications:
- Pain relief
- Fever reduction
- Inflammation
- Menstrual cramps
- Arthritis
- Pain relief
- Fever reduction
- Inflammation
- Rheumatoid arthritis
- Osteoarthritis
- Pain relief
- Fever reduction
- Inflammation
- Menstrual cramps
- Arthritis
- Pain relief
- Fever reduction
- Inflammation
- Rheumatoid arthritis
- Osteoarthritis
- Pain relief
- Fever reduction
- Inflammation
- Menstrual cramps
- Arthritis
- Pain relief
- Fever reduction
- Inflammation
- Rheumatoid arthritis
- Osteoarthritis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Montefiore Medical Center
Lead Sponsor